Видео ютуба по тегу Medicines: Lenalidomide

Graham Jackson, MD: Lenalidomide Maintenance Is Effective in All Types of Myeloma Patients
Graham Jackson, MD: Lenalidomide Maintenance Is Effective in All Types of Myeloma Patients
Lenalidomide maintenance – an active approach to treating MM?
Lenalidomide maintenance – an active approach to treating MM?
Lenalidomide's place in the myeloma treatment landscape
Lenalidomide's place in the myeloma treatment landscape
The impact of lenalidomide on second primary malignancies: long-term data from the Myeloma XI Trial
The impact of lenalidomide on second primary malignancies: long-term data from the Myeloma XI Trial
All About Revlimid (lenalidomide) #myeloma
All About Revlimid (lenalidomide) #myeloma
Managing lenalidomide-refractory myeloma patients
Managing lenalidomide-refractory myeloma patients
FIRST trial: Continuous lenalidomide plus dexamethasone for newly diagnosed multiple myeloma
FIRST trial: Continuous lenalidomide plus dexamethasone for newly diagnosed multiple myeloma
Lenalidomide versus thalidomide in myeloma
Lenalidomide versus thalidomide in myeloma
Revlimid : classe thérapeutique, indications, mécanisme d'action et effets secondaires
Revlimid : classe thérapeutique, indications, mécanisme d'action et effets secondaires
Lenalidomide/Dexamethasone vs. Clarithromycin/Leanlidomide/Dexamethasone in Myeloma
Lenalidomide/Dexamethasone vs. Clarithromycin/Leanlidomide/Dexamethasone in Myeloma
Lenalidomide (Revlimid) for Multiple Myeloma, Mantle Cell Lymphoma and Myelodysplastic Syndromes
Lenalidomide (Revlimid) for Multiple Myeloma, Mantle Cell Lymphoma and Myelodysplastic Syndromes
Myeloma: lenalidomide maintenance therapy
Myeloma: lenalidomide maintenance therapy
What impact do Revlimid® (lenalidomide) and Pomalyst® (pomalidomide) have on the bone marrow?
What impact do Revlimid® (lenalidomide) and Pomalyst® (pomalidomide) have on the bone marrow?
What is lenalidomide and when is it used for MDS?
What is lenalidomide and when is it used for MDS?
Teclistamab in Combination with Sub-Q Daratumumab and Lenalidomide in Myeloma Pts: MajesTEC-2
Teclistamab in Combination with Sub-Q Daratumumab and Lenalidomide in Myeloma Pts: MajesTEC-2
Combining bortezomib and lenalidomide-based regimens for frontline MM
Combining bortezomib and lenalidomide-based regimens for frontline MM
Pomalidomide In Lenalidomide-Refractory Patients
Pomalidomide In Lenalidomide-Refractory Patients
Myeloma Doctor Talks About Lenalidomide
Myeloma Doctor Talks About Lenalidomide
Single-agent lenalidomide maintenance after upfront autoSCT in newly diagnosed multiple myeloma
Single-agent lenalidomide maintenance after upfront autoSCT in newly diagnosed multiple myeloma
UK practice: pomalidomide in patients resistant to lenalidomide
UK practice: pomalidomide in patients resistant to lenalidomide